Xiaofei Tang

Fengtai, 100070, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

GTP-binding protein DIRAS2 inhibits ferroptosis in oral leukoplakia via regulating iron metabolism.

GTP-binding protein DIRAS2 inhibits ferroptosis in oral leukoplakia via regulating iron metabolism.

Journal: European journal of cell biology

Published: May 08, 2026

Azoxystrobin induces mitochondrial apoptosis by inhibiting cytochrome b Qo site of mitochondrial complex Ⅲ in oral leukoplakia cells and a mouse model.

Azoxystrobin induces mitochondrial apoptosis by inhibiting cytochrome b Qo site of mitochondrial complex Ⅲ in oral leukoplakia cells and a mouse model.

Journal: Archives of oral biology

Published: March 25, 2026

Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and Thr90 sites in oral leukoplakia.

Azoxystrobin induces mitochondrial dysfunction and mitochondrial pathway apoptosis by targeting the Prx1 Trp87 and Thr90 sites in oral leukoplakia.

Journal: Frontiers in pharmacology

Published: December 17, 2025

DIRAS2 promotes the progression of oral leukoplakia via suppressing ferroptosis.

DIRAS2 promotes the progression of oral leukoplakia via suppressing ferroptosis.

Journal: In vitro cellular & developmental biology. Animal

Published: September 22, 2025

The small GTP-binding Ras-like protein DIRAS2 promotes cell proliferation in oral leukoplakia via the RAF/MEK/MAPK pathway.

The small GTP-binding Ras-like protein DIRAS2 promotes cell proliferation in oral leukoplakia via the RAF/MEK/MAPK pathway.

Journal: Tissue & cell

Published: March 30, 2025

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis.

The interaction of PRDX1 with Cofilin promotes oral squamous cell carcinoma metastasis.

Journal: International journal of cancer

Published: January 17, 2024

Conditional knockout mouse model reveals a critical role of peroxiredoxin 1 in oral leukoplakia carcinogenesis.

Conditional knockout mouse model reveals a critical role of peroxiredoxin 1 in oral leukoplakia carcinogenesis.

Journal: Heliyon

Published: January 09, 2024

Induction of Peroxiredoxin 1 by Hypoxia Promotes Cellular Autophagy and Cell Proliferation in Oral Leukoplakia via HIF-1α/BNIP3 Pathway.

Induction of Peroxiredoxin 1 by Hypoxia Promotes Cellular Autophagy and Cell Proliferation in Oral Leukoplakia via HIF-1α/BNIP3 Pathway.

Journal: Journal of molecular histology

Published: December 17, 2023

Peroxiredoxin 1 Promotes Proinflammatory Cytokine Secretion in Human Dysplastic Oral Keratinocytes and Mouse Tongue Precancerous Tissues.

Peroxiredoxin 1 Promotes Proinflammatory Cytokine Secretion in Human Dysplastic Oral Keratinocytes and Mouse Tongue Precancerous Tissues.

Journal: Analytical cellular pathology (Amsterdam)

Published: November 03, 2023

Prx1/PHB2 axis mediates mitophagy in oral leukoplakia cellular senescence.

Prx1/PHB2 axis mediates mitophagy in oral leukoplakia cellular senescence.

Journal: Pathology, research and practice

Published: October 26, 2023

Corrigendum: Molar loss further exacerbates 2-VO-induced cognitive impairment associated with the activation of p38MAPK/NFκB pathway.

Corrigendum: Molar loss further exacerbates 2-VO-induced cognitive impairment associated with the activation of p38MAPK/NFκB pathway.

Journal: Frontiers in aging neuroscience

Published: November 16, 2022

Molar loss further exacerbates 2-VO-induced cognitive impairment associated with the activation of p38MAPK/NFκB pathway.

Molar loss further exacerbates 2-VO-induced cognitive impairment associated with the activation of p38MAPK/NFκB pathway.

Journal: Frontiers in aging neuroscience

Published: April 27, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026